Sildenafil Citrate Sildenafil powder,Sildenafil material
-
Post Date:
Jun 07,2017
-
Expiry Date:
Jun 07,2018
-
Detailed Description:
Cas No. :171599-83-0
Quantity: 50Kilograms
Price:1 USD Metric Tons
Payment Method: Western union,T/T,Money gram, Bitcoin
Sildenafil Citrate Effect
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).It acts by inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), an enzyme that promotes degradation of cGMP, which regulates blood flow in the penis.
The primary indication of sildenafil is treatment of erectile dysfunction (inability to sustain a satisfactory erection to complete intercourse). Its use is now standard treatment for erectile dysfunction in all settings, including diabetes.
Medical Uses
1)Sexual dysfunction
2)Pulmonary hypertension
3)Antidepressant-associated sexual dysfunction
4)Altitude sickness
Sildenafil Dosage
Viagra:for erectile dysfunction, comes in blue, diamond-shaped pills, in doses of 25, 50, or 100 milligrams. The patient takes a maximum of one pill in a 24-hour period, between 30 minutes to 1 hour before sexual intercourse.
Revatio:for pulmonary arterial hypertension, comes in white, round, film-coated tablets. Patients take one 20 mg Revatio tablet three times a day.
-
CAS Registry Number:
171599-83-0
-
Synonyms:
;Viagra;5-[2-Ethoxy-5-(4-methylpiperazin-1-yl-sulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazol[4,3d]pyrimidin-7-one citrate;5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate (1:1);5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-3-propyl-2,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one;Sidenafil citrate;
-
Molecular Formula:
C21H28N6O4S
-
Molecular Weight:
460.5498
-
Molecular Structure:
-
Company:
Wuhan Hengwo Scien-Tech Co., Ltd.
[ China ]
-
Contact:
Kevin
-
Tel:
+86-15372431628
-
Fax:
-
Email:
kevin@ycgmp.com
Inquiry